Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,727 | 408 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $563.57 | 46 | $0 (2022) |
| Lundbeck LLC | $542.23 | 45 | $0 (2024) |
| ABBVIE INC. | $534.30 | 50 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $528.00 | 38 | $0 (2024) |
| Corium, LLC | $457.04 | 31 | $0 (2024) |
| Alkermes, Inc. | $439.33 | 24 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $400.42 | 24 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $379.95 | 26 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $375.09 | 31 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $374.58 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,515 | 95 | Supernus Pharmaceuticals, Inc. ($228.80) |
| 2023 | $1,100 | 78 | Corium, LLC ($155.51) |
| 2022 | $1,658 | 122 | Sunovion Pharmaceuticals Inc. ($248.32) |
| 2021 | $1,454 | 113 | Sunovion Pharmaceuticals Inc. ($315.25) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/11/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Opioid Use Disorder | ||||||
| 12/10/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $19.76 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/03/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.14 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $45.97 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: OUD | ||||||
| 11/12/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $4.04 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.77 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Opioid Use Disorder | ||||||
| 10/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Neuropsychiatry | ||||||
| 10/03/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $19.71 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 184 | 487 | $73,312 | $26,943 |
| 2022 | 3 | 64 | 202 | $26,585 | $8,558 |
| 2021 | 3 | 84 | 367 | $35,133 | $14,020 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 51 | 188 | $22,560 | $7,523 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 83 | $17,534 | $6,160 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 130 | $19,500 | $6,092 | 31.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 72 | $9,000 | $5,575 | 61.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 14 | 14 | $4,718 | $1,593 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 164 | $24,125 | $7,862 | 32.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 14 | 17 | $2,040 | $678.94 | 33.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 16 | 21 | $420.00 | $16.80 | 4.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 236 | $30,458 | $13,057 | 42.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 18 | $2,325 | $581.25 | 25.0% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 30 | 113 | $2,350 | $381.94 | 16.3% |
About Cheri Frederick
Cheri Frederick is a Psychiatric/Mental Health healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2020. The National Provider Identifier (NPI) number assigned to this provider is 1548868268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cheri Frederick has received a total of $5,727 in payments from pharmaceutical and medical device companies, with $1,515 received in 2024. These payments were reported across 408 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,727).
As a Medicare-enrolled provider, Frederick has provided services to 332 Medicare beneficiaries, totaling 1,056 services with total Medicare billing of $49,521. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Elizabethtown, KY
- Active Since 10/14/2020
- Last Updated 10/14/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548868268
Products in Payments
- REXULTI (Drug) $666.34
- LATUDA (Drug) $563.57
- VRAYLAR (Drug) $534.30
- ARISTADA (Drug) $400.42
- INGREZZA (Drug) $400.42
- TRINTELLIX (Drug) $375.09
- ABILIFY MAINTENA (Drug) $354.34
- Azstarys (Drug) $354.09
- HETLIOZ (Drug) $279.89
- Qelbree (Drug) $228.80
- CAPLYTA (Drug) $215.52
- Austedo XR (Drug) $210.65
- AUSTEDO (Drug) $169.30
- JORNAY PM (Drug) $142.93
- SPRAVATO (Drug) $128.20
- AZSTARYS (Drug) $102.95
- FANAPT (Drug) $94.69
- SUBLOCADE (Drug) $92.64
- Auvelity (Drug) $55.94
- BRIXADI (Drug) $53.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Elizabethtown
Mrs. Amanda Johnson, Aprn, APRN
Psychiatric/Mental Health — Payments: $11,949
Jason Dunn, Aprn, APRN
Psychiatric/Mental Health — Payments: $8,363
Donald Blackburn, Aprn, APRN
Psychiatric/Mental Health — Payments: $6,434
Sandra Aubrey, Aprn, APRN
Psychiatric/Mental Health — Payments: $5,793
Mrs. Kristen Howell, Aprn, APRN
Psychiatric/Mental Health — Payments: $5,073
John Palmer, Aprn, Pmhnp, APRN, PMHNP
Psychiatric/Mental Health — Payments: $3,007